Cullinan Therapeutics, Inc. (CGEM)
(Delayed Data from NSDQ)
$19.60 USD
+0.74 (3.92%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $19.42 -0.18 (-0.92%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For CGEM
-
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports First Quarter 2023 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Results